Integra LifeSciences Holdings Corporation (IART)
USD 19.49
(-2.84%)
USD 19.49
(-2.84%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.78 Billion USD | -2.77% |
| 2022 | 3.88 Billion USD | 2.84% |
| 2021 | 3.78 Billion USD | 4.63% |
| 2020 | 3.61 Billion USD | 9.44% |
| 2019 | 3.3 Billion USD | 6.29% |
| 2018 | 3.1 Billion USD | -3.22% |
| 2017 | 3.21 Billion USD | 77.62% |
| 2016 | 1.8 Billion USD | 1.87% |
| 2015 | 1.77 Billion USD | 12.42% |
| 2014 | 1.57 Billion USD | 31.97% |
| 2013 | 1.19 Billion USD | 2.8% |
| 2012 | 1.16 Billion USD | 1.7% |
| 2011 | 1.14 Billion USD | 12.46% |
| 2010 | 1.01 Billion USD | 8.21% |
| 2009 | 940.1 Million USD | -9.12% |
| 2008 | 1.03 Billion USD | 26.46% |
| 2007 | 818.01 Million USD | 33.31% |
| 2006 | 613.61 Million USD | 36.84% |
| 2005 | 448.43 Million USD | -1.81% |
| 2004 | 456.71 Million USD | 10.71% |
| 2003 | 412.52 Million USD | 50.19% |
| 2002 | 274.66 Million USD | 20.69% |
| 2001 | 227.58 Million USD | 163.06% |
| 2000 | 86.51 Million USD | 30.49% |
| 1999 | 66.3 Million USD | 91.07% |
| 1998 | 34.7 Million USD | -9.64% |
| 1997 | 38.4 Million USD | -21.15% |
| 1996 | 48.7 Million USD | 151.03% |
| 1995 | 19.4 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.07 Billion USD | 7.83% |
| 2024 Q2 | 4.07 Billion USD | -0.09% |
| 2024 Q3 | 4.06 Billion USD | -0.21% |
| 2023 Q2 | 3.77 Billion USD | 0.94% |
| 2023 Q4 | 3.78 Billion USD | 1.14% |
| 2023 Q1 | 3.74 Billion USD | -3.79% |
| 2023 FY | 3.78 Billion USD | -2.77% |
| 2023 Q3 | 3.73 Billion USD | -1.01% |
| 2022 FY | 3.88 Billion USD | 2.84% |
| 2022 Q2 | 3.75 Billion USD | 2.2% |
| 2022 Q1 | 3.67 Billion USD | -2.92% |
| 2022 Q3 | 3.8 Billion USD | 1.44% |
| 2022 Q4 | 3.88 Billion USD | 2.17% |
| 2021 Q3 | 3.77 Billion USD | 1.66% |
| 2021 Q2 | 3.71 Billion USD | -0.77% |
| 2021 FY | 3.78 Billion USD | 4.63% |
| 2021 Q1 | 3.74 Billion USD | 3.5% |
| 2021 Q4 | 3.78 Billion USD | 0.21% |
| 2020 Q2 | 3.39 Billion USD | -1.62% |
| 2020 Q3 | 922.3 Million USD | -72.81% |
| 2020 Q4 | 3.61 Billion USD | 291.97% |
| 2020 FY | 3.61 Billion USD | 9.44% |
| 2020 Q1 | 3.44 Billion USD | 4.37% |
| 2019 Q1 | 3.2 Billion USD | 3.15% |
| 2019 Q4 | 3.3 Billion USD | -1.3% |
| 2019 FY | 3.3 Billion USD | 6.29% |
| 2019 Q3 | 3.34 Billion USD | 1.71% |
| 2019 Q2 | 3.29 Billion USD | 2.64% |
| 2018 Q3 | 3.17 Billion USD | -0.22% |
| 2018 FY | 3.1 Billion USD | -3.22% |
| 2018 Q4 | 3.1 Billion USD | -2.23% |
| 2018 Q2 | 3.18 Billion USD | -1.91% |
| 2018 Q1 | 3.24 Billion USD | 1.13% |
| 2017 Q1 | 2.04 Billion USD | 13.33% |
| 2017 FY | 3.21 Billion USD | 77.62% |
| 2017 Q4 | 3.21 Billion USD | 32.8% |
| 2017 Q3 | 2.41 Billion USD | 15.09% |
| 2017 Q2 | 2.1 Billion USD | 2.54% |
| 2016 Q1 | 1.83 Billion USD | 3.13% |
| 2016 Q2 | 1.81 Billion USD | -0.88% |
| 2016 FY | 1.8 Billion USD | 1.87% |
| 2016 Q3 | 1.82 Billion USD | 0.73% |
| 2016 Q4 | 1.8 Billion USD | -1.07% |
| 2015 Q1 | 1.55 Billion USD | -1.76% |
| 2015 FY | 1.77 Billion USD | 12.42% |
| 2015 Q3 | 1.82 Billion USD | 11.58% |
| 2015 Q2 | 1.63 Billion USD | 5.62% |
| 2015 Q4 | 1.77 Billion USD | -2.9% |
| 2014 Q2 | 1.56 Billion USD | 0.46% |
| 2014 Q3 | 1.54 Billion USD | -1.11% |
| 2014 Q4 | 1.57 Billion USD | 2.13% |
| 2014 Q1 | 1.55 Billion USD | 30.07% |
| 2014 FY | 1.57 Billion USD | 31.97% |
| 2013 Q2 | 1.18 Billion USD | 2.68% |
| 2013 FY | 1.19 Billion USD | 2.8% |
| 2013 Q4 | 1.19 Billion USD | 1.03% |
| 2013 Q3 | 1.18 Billion USD | -0.29% |
| 2013 Q1 | 1.15 Billion USD | -0.61% |
| 2012 Q2 | 1.16 Billion USD | 0.3% |
| 2012 Q3 | 1.18 Billion USD | 2.04% |
| 2012 Q4 | 1.16 Billion USD | -1.85% |
| 2012 FY | 1.16 Billion USD | 1.7% |
| 2012 Q1 | 1.15 Billion USD | 1.25% |
| 2011 Q1 | 1 Billion USD | -1.01% |
| 2011 Q2 | 1.15 Billion USD | 14.58% |
| 2011 Q3 | 1.17 Billion USD | 1.8% |
| 2011 FY | 1.14 Billion USD | 12.46% |
| 2011 Q4 | 1.14 Billion USD | -2.6% |
| 2010 Q4 | 1.01 Billion USD | 6.05% |
| 2010 FY | 1.01 Billion USD | 8.21% |
| 2010 Q3 | 959.27 Million USD | 1.86% |
| 2010 Q2 | 941.79 Million USD | 0.4% |
| 2010 Q1 | 937.99 Million USD | -0.22% |
| 2009 Q3 | 973.23 Million USD | 2.84% |
| 2009 Q2 | 946.37 Million USD | -4.93% |
| 2009 FY | 940.1 Million USD | -9.12% |
| 2009 Q4 | 940.1 Million USD | -3.4% |
| 2009 Q1 | 995.41 Million USD | -3.77% |
| 2008 Q3 | 960.74 Million USD | 11.4% |
| 2008 Q1 | 972.65 Million USD | 18.9% |
| 2008 FY | 1.03 Billion USD | 26.46% |
| 2008 Q2 | 862.45 Million USD | -11.33% |
| 2008 Q4 | 1.03 Billion USD | 7.67% |
| 2007 Q2 | 776.49 Million USD | 24.62% |
| 2007 FY | 818.01 Million USD | 33.31% |
| 2007 Q4 | 818.01 Million USD | 0.98% |
| 2007 Q3 | 810.07 Million USD | 4.33% |
| 2007 Q1 | 623.07 Million USD | 1.54% |
| 2006 FY | 613.61 Million USD | 36.84% |
| 2006 Q3 | 604.46 Million USD | 6.75% |
| 2006 Q2 | 566.21 Million USD | 15.17% |
| 2006 Q1 | 491.63 Million USD | 9.63% |
| 2006 Q4 | 613.61 Million USD | 1.52% |
| 2005 Q1 | 470.4 Million USD | 3.0% |
| 2005 FY | 448.43 Million USD | -1.81% |
| 2005 Q4 | 448.43 Million USD | -3.75% |
| 2005 Q3 | 465.88 Million USD | 3.14% |
| 2005 Q2 | 451.68 Million USD | -3.98% |
| 2004 Q1 | 421.13 Million USD | 2.09% |
| 2004 FY | 456.71 Million USD | 10.71% |
| 2004 Q4 | 456.71 Million USD | 3.75% |
| 2004 Q3 | 440.18 Million USD | 1.1% |
| 2004 Q2 | 435.4 Million USD | 3.39% |
| 2003 Q2 | 392.53 Million USD | 10.03% |
| 2003 FY | 412.52 Million USD | 50.19% |
| 2003 Q4 | 412.52 Million USD | 2.48% |
| 2003 Q3 | 402.52 Million USD | 2.55% |
| 2003 Q1 | 356.75 Million USD | 29.89% |
| 2002 Q2 | 234.39 Million USD | 3.36% |
| 2002 Q3 | 242.57 Million USD | 3.49% |
| 2002 Q4 | 274.66 Million USD | 13.23% |
| 2002 FY | 274.66 Million USD | 20.69% |
| 2002 Q1 | 226.76 Million USD | -0.36% |
| 2001 FY | 227.58 Million USD | 163.06% |
| 2001 Q1 | 91.07 Million USD | 5.28% |
| 2001 Q2 | 94.19 Million USD | 3.42% |
| 2001 Q4 | 227.58 Million USD | 10.18% |
| 2001 Q3 | 206.55 Million USD | 119.29% |
| 2000 Q3 | 85.76 Million USD | 12.41% |
| 2000 Q1 | 73.69 Million USD | 11.15% |
| 2000 FY | 86.51 Million USD | 30.49% |
| 2000 Q4 | 86.51 Million USD | 0.88% |
| 2000 Q2 | 76.28 Million USD | 3.52% |
| 1999 Q1 | 66.7 Million USD | 92.22% |
| 1999 Q2 | 66.8 Million USD | 0.15% |
| 1999 FY | 66.3 Million USD | 91.07% |
| 1999 Q3 | 64 Million USD | -4.19% |
| 1999 Q4 | 66.3 Million USD | 3.59% |
| 1998 Q4 | 34.7 Million USD | -9.87% |
| 1998 Q1 | 36.1 Million USD | -5.99% |
| 1998 Q2 | 37.4 Million USD | 3.6% |
| 1998 Q3 | 38.5 Million USD | 2.94% |
| 1998 FY | 34.7 Million USD | -9.64% |
| 1997 Q3 | 43.5 Million USD | -3.76% |
| 1997 FY | 38.4 Million USD | -21.15% |
| 1997 Q1 | 47 Million USD | -3.49% |
| 1997 Q2 | 45.2 Million USD | -3.83% |
| 1997 Q4 | 38.4 Million USD | -11.72% |
| 1996 FY | 48.7 Million USD | 151.03% |
| 1996 Q3 | 50.9 Million USD | -3.23% |
| 1996 Q2 | 52.6 Million USD | -2.05% |
| 1996 Q1 | 53.7 Million USD | 176.8% |
| 1996 Q4 | 48.7 Million USD | -4.32% |
| 1995 FY | 19.4 Million USD | 0.0% |
| 1995 Q3 | 22.2 Million USD | 0.0% |
| 1995 Q4 | 19.4 Million USD | -12.61% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -11957.604% |
| BrainsWay Ltd. | 62.97 Million USD | -5905.825% |
| Cerus Corporation | 197.74 Million USD | -1812.529% |
| Envoy Medical, Inc. | 7.64 Million USD | -49402.461% |
| electroCore, Inc. | 16.38 Million USD | -22979.197% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -49067.811% |
| IceCure Medical Ltd | 16.41 Million USD | -22946.849% |
| Inogen, Inc. | 326.19 Million USD | -1059.429% |
| OrthoPediatrics Corp. | 449.58 Million USD | -741.216% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -13768.676% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -22711.906% |
| MaxCyte, Inc. | 268.27 Million USD | -1309.748% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -46606.698% |
| Nexalin Technology, Inc. | 3.63 Million USD | -104032.034% |
| Orthofix Medical Inc. | 925.31 Million USD | -308.724% |
| PAVmed Inc | 33.11 Million USD | -11319.391% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -2536.414% |
| RxSight, Inc. | 182.55 Million USD | -1971.755% |
| Sight Sciences, Inc. | 166.65 Million USD | -2169.406% |
| SI-BONE, Inc. | 230.42 Million USD | -1541.31% |
| TELA Bio, Inc. | 78.04 Million USD | -4745.721% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -1401.343% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -35146.859% |
| Acutus Medical, Inc. | 53.96 Million USD | -6908.873% |
| Talis Biomedical Corporation | 98.34 Million USD | -3745.829% |
| Spectral AI, Inc. | 10.69 Million USD | -35272.129% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -1629.715% |
| CVRx, Inc. | 115.22 Million USD | -3182.149% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -6347.194% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -121302.275% |
| Bioventus Inc. | 810.91 Million USD | -366.388% |
| Venus Concept Inc. | 93.65 Million USD | -3938.256% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -14601.605% |
| LivaNova PLC | 2.42 Billion USD | -55.665% |
| 908 Devices Inc. | 202.98 Million USD | -1763.223% |
| Alphatec Holdings, Inc. | 805.2 Million USD | -369.691% |
| Nemaura Medical Inc. | 14.56 Million USD | -25869.426% |
| NeuroPace, Inc. | 107.65 Million USD | -3413.194% |
| LENSAR, Inc. | 69.58 Million USD | -5335.062% |
| Apyx Medical Corporation | 79.24 Million USD | -4672.827% |
| Cutera, Inc. | 346.29 Million USD | -992.142% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -8901.304% |
| BioSig Technologies, Inc. | 1.79 Million USD | -210244.16% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -1297.465% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -8765.212% |
| Axonics, Inc. | 719.92 Million USD | -425.332% |
| Outset Medical, Inc. | 313.8 Million USD | -1105.219% |
| IRIDEX Corporation | 34.43 Million USD | -10882.658% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | -834.477% |
| IRadimed Corporation | 92.15 Million USD | -4003.893% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -71883.022% |
| INVO Bioscience, Inc. | 20.88 Million USD | -18006.217% |
| Telesis Bio, Inc. | 70.41 Million USD | -5271.303% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -2354.203% |
| Varex Imaging Corporation | 1.24 Billion USD | -202.656% |
| Quipt Home Medical Corp. | 247.4 Million USD | -1428.644% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -40522.857% |
| Pulmonx Corporation | 178.95 Million USD | -2013.421% |
| Dynatronics Corporation | 25.94 Million USD | -14479.439% |
| Modular Medical, Inc. | 13.8 Million USD | -27291.816% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -35156.717% |
| Semler Scientific, Inc. | 78.06 Million USD | -4744.665% |
| InMode Ltd. | 863.28 Million USD | -338.092% |
| Bruker Corporation | 4.24 Billion USD | 11.01% |
| Cytosorbents Corporation | 53.26 Million USD | -7000.907% |
| DexCom, Inc. | 6.26 Billion USD | 39.628% |
| Align Technology, Inc. | 6.08 Billion USD | 37.836% |
| Viveve Medical, Inc. | 25.91 Million USD | -14494.945% |
| ZimVie Inc. | 1.2 Billion USD | -213.768% |
| Movano Inc. | 9.42 Million USD | -40044.231% |
| Cytek Biosciences, Inc. | 497.66 Million USD | -659.94% |
| Nexalin Technology, Inc. | 3.63 Million USD | -104032.034% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -6347.194% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | -296.993% |
| Profound Medical Corp. | 43.68 Million USD | -8557.141% |
| Insulet Corporation | 2.58 Billion USD | -46.124% |
| enVVeno Medical Corporation | 48.63 Million USD | -7676.268% |
| Surmodics, Inc. | 185.73 Million USD | -1936.25% |
| iCAD, Inc. | 41.41 Million USD | -9031.267% |
| Nuwellis, Inc. | 9.77 Million USD | -38610.215% |
| Biotricity, Inc. | 5.94 Million USD | -63541.707% |
| iRhythm Technologies, Inc. | 433.14 Million USD | -773.148% |
| Aethlon Medical, Inc. | 8.24 Million USD | -45764.616% |
| InspireMD, Inc. | 47.64 Million USD | -7838.182% |
| PAVmed Inc. | 33.11 Million USD | -11319.391% |
| BIOLASE, Inc. | 35.1 Million USD | -10674.588% |
| Beyond Air, Inc. | 56.96 Million USD | -6539.61% |
| FONAR Corporation | 214.24 Million USD | -1665.255% |
| AxoGen, Inc. | 196.82 Million USD | -1821.478% |
| Vivani Medical, Inc. | 45.79 Million USD | -8158.157% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -1243.809% |
| Inari Medical, Inc. | 674.23 Million USD | -460.93% |
| UFP Technologies, Inc. | 404.13 Million USD | -835.821% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -16063.335% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -39697.359% |
| Tenon Medical, Inc. | 6.34 Million USD | -59505.8% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -40103.976% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -3548.886% |
| AdaptHealth Corp. | 4.61 Billion USD | 18.136% |
| Sintx Technologies, Inc. | 15.36 Million USD | -24514.305% |
| NanoVibronix, Inc. | 6.67 Million USD | -56567.486% |
| Quanterix Corporation | 425.01 Million USD | -789.856% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -40522.857% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -6939.269% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | -116.607% |
| TransMedics Group, Inc. | 706.04 Million USD | -435.657% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -5884.916% |
| NeuroMetrix, Inc. | 21.42 Million USD | -17552.68% |
| Hyperfine, Inc. | 94.19 Million USD | -3914.892% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -1307.822% |
| Biomerica, Inc. | 9.25 Million USD | -40768.684% |
| Bone Biologics Corporation | 3.73 Million USD | -101083.194% |
| AVITA Medical, Inc. | 144.33 Million USD | -2520.194% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -77582.323% |
| Silk Road Medical, Inc | 265.3 Million USD | -1325.503% |